Key result
The T allele of rs2107614 was significantly associated with an increased odds of uncontrolled hypertension (AOR 6.69, 95% CI 1.42-31.55, p=0.016) among South African adults on antihypertensive therapy.
Why the study?
To describe SNPs in hydrochlorothiazide-associated genes and assess their correlation with blood pressure control among South African adults with hypertension.
Are specific SNPs in hydrochlorothiazide-associated genes associated with uncontrolled blood pressure in South African adults treated for hypertension?
Cross-Sectional (n=291)
Yes
Are specific SNPs in hydrochlorothiazide-associated genes associated with uncontrolled blood pressure in South African adults treated for hypertension?
Odds Ratio: 6.69 (95% CI 1.42–31.55)
p-value: p=0.016
Specific genetic variants in pharmacogenes related to hydrochlorothiazide are significantly associated with poor blood pressure control in South African adults, suggesting a potential future role for targeted pharmacogenomic testing.
Should not yet guide pharmacogenomic testing in practice; leaves open prospective validation of rs2107614 in African hypertension cohorts.
This study described single nucleotide polymorphisms (SNPs) in hydrochlorothiazide-associated genes and further assessed their correlation with blood pressure control among South African adults living with hypertension. A total of 291 participants belonging to the Nguni tribes of South Africa on treatment for hypertension were recruited. Nineteen SNPs in hydrochlorothiazide pharmacogenes were selected and genotyped using MassArray. Uncontrolled hypertension was defined as blood pressure ≥140/90 mmHg. The association between genotypes, alleles and blood pressure response to treatment was determined by conducting multivariate logistic regression model analysis. The majority of the study participants were female (73.19%), Xhosa (54.98%) and had blood pressure ≥140/90 mmHg (68.73%). Seventeen SNPs were observed among the Xhosa tribe, and two (rs2070744 and rs7297610) were detected among Swati and Zulu participants. Furthermore, alleles T of rs2107614 (AOR = 6.69; 95%CI 1.42–31.55; p = 0.016) and C of rs2776546 (AOR = 3.78; 95%CI 1.04–13.74; p = 0.043) were independently associated with uncontrolled hypertension, whilst rs2070744 TC (AOR = 38.76; 95%CI 5.54–270.76; p = 0.00023), CC (AOR = 10.44; 95%CI 2.16–50.29; p = 0.003) and allele T of rs7297610 (AOR = 1.86; 95%CI 1.09–3.14; p = 0.023) were significantly associated with uncontrolled hypertension among Zulu and Swati participants. We confirmed the presence of SNPs associated with hydrochlorothiazide, some of which were significantly associated with uncontrolled hypertension in the study sample. Findings open doors for further studies on personalized therapy for hypertension in the country.
No takes yet. Share an insight, caveat, or question.
Masilela et al. (2020) conducted a cross-sectional in Hypertension (n=291). SNPs in hydrochlorothiazide-associated genes (e.g., rs2107614 allele T) vs. Alternative alleles or genotypes was evaluated on Uncontrolled hypertension (blood pressure ≥140/90 mmHg) (AOR 6.69, 95% CI 1.42-31.55, p=0.016). The T allele of rs2107614 was significantly associated with an increased odds of uncontrolled hypertension (AOR 6.69, 95% CI 1.42-31.55, p=0.016) among South African adults on antihypertensive therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: